Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need

18 Mar 2022

Beckman Coulter is introducing drug tests in agreement with Saladax Biomedical, Inc.
Read More
Contact Beckman Coulter (UK) Ltd

Related Articles

Beckman Coulter’s DxI 9000 Analyser

Beckman Coulter unveils Immunoassay Analyser with No Daily Maintenance

Added: 15 May 2023

Beckman Coulter claims its DxI 9000 Access Immunoassay Analyser is the most productive immunoassay …

The MeMed BV test uses machine learning to integrate measurements of three key host-immune proteins

Beckman Coulter and MeMed Expand Access to Proven Host Immune Response Diagnostic

Added: 20 Feb 2023

Beckman Coulter Diagnostics has joined forces with MeMed, from the emerging field of advanced host-…

Beckman Coulter partners with smart4diagnostics to reduce the preanalytical data gap

Beckman Coulter partners with Smart4Diagnostics to close the data gap between blood collection and lab analysis

Added: 8 Aug 2022

Beckman Coulter has announced a partnership with German-based Smart4Diagnostics to close the preana…